Judges Scientific plc
("Judges Scientific" or the "Company")
Grant of Options
Judges Scientific announces that it has issued options over 13,200 new ordinary shares of 5 pence each in the Company ("Ordinary Shares") at an exercise price per share of £95.00, being the closing mid price on 23 January 2024.
13,200 options have been awarded in total by the Remuneration Committee to certain of the Directors, as shown in the table below, to retain and incentivise them. Vesting of the options after three years is subject to the achievement of 5% compound growth in adjusted earnings per share over the vesting period, and to continued employment.
| Director | Number of options | Option Scheme | Vesting date | Expiry date |
| David Cicurel | 4,400 | Unapproved | 23/01/2027 | 22/01/2034 |
| Brad Ormsby | 4,400 | Unapproved | 23/01/2027 | 22/01/2034 |
| Mark Lavelle | 4,400 | Unapproved | 23/01/2027 | 22/01/2034 |
- Ends -
| - For further information please contact:
|
|
| |
| Judges Scientific plc David Cicurel, CEO Brad Ormsby, CFO Tel: +44 (0) 20 3829 6970
| Shore Capital (Nominated Adviser & Joint Broker) Stephane Auton Iain Sexton Tel: +44 (0) 20 7408 4090
| | |
| Liberum (Joint Broker) Edward Mansfield Nikhil Varghese Tel : +44 (0) 20 3100 2222
| Investec Bank plc (Joint Broker) Virginia Bull Carlton Nelson Tel: +44 (0) 207 597 4000 | | |
| Alma (Financial Public Relations) Sam Modlin Rebecca Sanders-Hewett Joe Pederzolli Tel: +44 (0) 20 3405 0205 | | | |
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 22 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com
Judges Scientific plc
Director/PDMR Shareholding
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| David Cicurel | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Chief Executive Officer | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Judges Scientific plc | ||||
| b)
| LEI
| 2138004EXWWPTW1JOL31 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares in Judges Scientific plc
GB0032398678
| ||||
| b)
| Nature of the transaction
| Grant of Options | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
| N/A (single transaction) | ||||
| e)
| Date of the transaction
| 23/01/24 | ||||
| f)
| Place of the transaction
| Off market | ||||
Judges Scientific plc
Director/PDMR Shareholding
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Bradley Ormsby | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Group Finance Director | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Judges Scientific plc | ||||
| b)
| LEI
| 2138004EXWWPTW1JOL31 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares in Judges Scientific plc
GB0032398678
| ||||
| b)
| Nature of the transaction
| Grant of Options | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
| N/A (single transaction) | ||||
| e)
| Date of the transaction
| 23/01/24 | ||||
| f)
| Place of the transaction
| Off market | ||||
Judges Scientific plc
Director/PDMR Shareholding
| 1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
| a)
| Name
| Mark Lavelle | ||||
| 2
| Reason for the notification
| |||||
| a)
| Position/status
| Chief Operating Officer | ||||
| b)
| Initial notification /Amendment
| Initial notification | ||||
| 3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
| a)
| Name
| Judges Scientific plc | ||||
| b)
| LEI
| 2138004EXWWPTW1JOL31 | ||||
| 4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
| a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares in Judges Scientific plc
GB0032398678
| ||||
| b)
| Nature of the transaction
| Grant of Options | ||||
| c)
| Price(s) and volume(s)
|
| ||||
| d)
| Aggregated information
- Aggregated volume
- Price
| N/A (single transaction) | ||||
| e)
| Date of the transaction
| 23/01/24 | ||||
| f)
| Place of the transaction
| Off market | ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
